PDCD1 and neoplasm: Fourth-generation CAR-T cells (T cells redirected for universal cytokine killing, TRUCK) exhibit more effective anti-tumor activity by releasing cytokines, antibodies (e.g., anti-PD-1) and enzymes that can degrade the extracellular matrix in solid tumors.